Dendritic Cells in Anticancer Vaccination: Rationale for Ex Vivo Loading or In Vivo Targeting

Dendritic cells (DCs) have shown great potential as a component or target in the landscape of cancer immunotherapy. Different in vivo and ex vivo strategies of DC vaccine generation with different outcomes have been proposed. Numerous clinical trials have demonstrated their efficacy and safety in ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Baldin, Alexey V., Savvateeva, Lyudmila V., Bazhin, Alexandr V., Zamyatnin, Andrey A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139354/
https://www.ncbi.nlm.nih.gov/pubmed/32150821
http://dx.doi.org/10.3390/cancers12030590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139354/
https://www.ncbi.nlm.nih.gov/pubmed/32150821
http://dx.doi.org/10.3390/cancers12030590

Ejemplares similares